Corrigendum: Genetically Predicted Fibroblast Growth Factor 23 and Major Cardiovascular Diseases, Their Risk Factors, Kidney Function, and Longevity: A Two-Sample Mendelian Randomization Study
Guardado en:
Autores principales: | Ying Liang, Shan Luo, C. Mary Schooling, Shiu Lun Au Yeung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1803f89a354c4181bab803a5638814de |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetically Predicted Fibroblast Growth Factor 23 and Major Cardiovascular Diseases, Their Risk Factors, Kidney Function, and Longevity: A Two-Sample Mendelian Randomization Study
por: Ying Liang, et al.
Publicado: (2021) -
Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
por: José Alberto Navarro-García, et al.
Publicado: (2021) -
Association of genetically predicted blood sucrose with coronary heart disease and its risk factors in Mendelian randomization
por: Ting Zhang, et al.
Publicado: (2020) -
Cyclooxygenase-2 and hypoxia-regulated proteins are modulated by basic fibroblast growth factor in acute renal failure
por: Villanueva,Sandra, et al.
Publicado: (2012) -
Eje somatotrópico y marcadores moleculares del metabolismo mineral en niños en diálisis
por: Ceballos Osorio,María Luisa, et al.
Publicado: (2017)